Liver Disorders Treatments in Italy

Humanitas General Hospital

Rozzano, Milan, Italy
accreditation accreditation

Humanitas Hospital is a well-known center of excellence for research and treatment of immune system-related disease, from cancer to cardiova... Read More

Humanitas Hospital is a well-known center of excellence for research and treatment of immune system-related disease, from cancer to cardiovascular diseases, inflammatory and autoimmune diseases. It is a Highly specialized teaching and research hospital. It combines specialized centers for the treatment of cancers, cardiovascular diseases, neurological and orthopedic disorders, equally an Ophthalmology Centre and a Fertility Center. The hospital is also fortified with Emergency and Radiotherapy areas.

Humanitas Hostpital accommodates 115 operation theatres, 70.350 annual surgeries, 1.882 physicians, 125.400 annual inpatient admissions, 7.000.000 annual outpatient visits.

Over 300 researchers work at the Research and University Teaching Center, which is fully integrated with the hospital, taking advantage of front-line technology such as the lately acquired two-photon microscope. The research hospital functions in close teamwork of 650 medical practitioner of the hospital in order to facilitate translation, i.e. the direct application of the latest advances in healthcare through a systematic and ongoing process of innovation.

Scientists and researchers from 16 countries, across 4 continents, implement innovative research in immunology and are involved in studies on high impact non-communicable diseases, e.g. cancer, myocardial infarction, stroke and autoimmune diseases.

In 2015, Humanitas’ scientific production continuously increases in value, attaining very high heights, as indicated by bibliometric indexes, more than 3,000 Impact Factor points in 2015 (ranking among the first Clinical Research Institutes (IRCCS) in scientific output), specifically focusing on the immune system.

In 2005, in recognition of its excellence, Humanitas was accredited by the Italian Ministry of Health as a Clinical Research Institute (IRCCS).
SCImago Research Group assesses the publications of over 5,000 research centers and publishes a statement which evaluates institutions around the world with meaningful scientific output annually.

The assessment of 2014 Humanitas Scientific Production carried out by SCImago Research Group places Humanitas as one of the best centers globally.

In the Excellence rank index, the IRCCS of Rozzano ranks among the best 10% worldwide (315 out of 4,849 institutes) and in West Europe (141 out of 1535 centers), while in Italy it ranks within the top 5% (8 out of 163).

Presently, Humanitas is collaborated with international centers into the worldwide research scenery. Similarly, Humanitas also takes part to global cooperation networks, embarking on projects with other Countries in Europe, with the United States and with Far East countries.
Humanitas was the first Italian general hospital and one of the few in Europe, to be accredited for quality by the Joint Commission International (JCI) in 2002, 2006, 2009, 2012 and 2015. Considered by Harvard University as one of the four most innovative hospitals in the world, Humanitas is a case study of the Harvard Business School for its organizational model, which combines economic, developmental and social responsibility. Close

Paolo Omodei Member: Doctor Paolo Omodei